Xenopsin-Related Peptide 2 (XP-2)(117442-29-2)
- Name: Xenopsin-Related Peptide 2 (XP-2)
- Synonyms:Xenopsin,1-(N-L-phenylalanyl-L-histidine)-2-L-proline-; Xenopsin-related peptide 2(turkey proventriculus) (9CI); 1: PN: WO2008050769 SEQID: 1 unclaimed protein;XP 2; Xenin 9; Xenopsin-related peptide (rat)
- Molecular Formula:C60H88 N16 O10
- Molecular Weight:1193.46
- CAS Registry Number:117442-29-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 21272-91-3/[(benzylsulfonyl)(bromo)nitromethyl]benzene
- 77162-07-3/5(6)-AZIDOFLUORESCEIN DIACETATE
- 74305-94-5/4-Pyridinecarbohydrazonoyl bromide, N-(4-nitrophenyl)-
- 84478-72-8/5-amino-2-chloro-4-fluoro-phenol
- 96573-85-2/carbamodithioic acid - methanamine (1:1)
- 7753-12-0/2,4,6-tris(4-methoxyphenyl)-1,3,5-triazine
- 68834-10-6/2,5-Furandione, polymer with methyloxirane polymer with oxirane ether with 1,2,3-propanetriol (3:1)
- 134029-45-1/2-(1H-Indol-3-yl)-4-(6-bromo-1H-indol-3-yl)-1H-imidazole
- 493-10-7/Octahydro-4H-quinolizine
- 38493-73-1/ethyl 2-{[(4-chlorophenyl)carbamoyl](hydroxy)amino}benzoate
- 65929-17-1/sodium (2S,5R,6R)-6-{[({[2-(4-formylpiperazin-1-yl)-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-6-yl]carbonyl}amino)(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
- 80222-84-0/(E)-N~2~-{[5-chloro-2-(methylamino)phenyl](phenyl)methylidene}glycinamide
- 77476-13-2/Hydrazinecarboximidamide, N-methyl-2-[1-(2-phenanthrenyl)ethylidene]-, monohydrochloride
- 78700-53-5/N-(tert-butoxycarbonyl)glycyltryptophan
- 6107-36-4/6-({3-[(1-methylethoxy)carbonyl]-4,5,6,7-tetrahydro-1-benzothiophen-2-yl}carbamoyl)cyclohex-3-ene-1-carboxylic acid
- 3701-12-0/{[(E)-(4-methylphenyl)diazenyl](phenyl)methyl}propanedinitrile
- 21301-41-7/N-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]-4-methyl-benzenesulfonamide
- 14368-49-1/4-nitrobenzenediazonium
- 117442-29-2/Xenopsin-Related Peptide 2 (XP-2)
- 108659-72-9/6,8-dibromo-2-[(butan-2-ylsulfanyl)methyl]-3-(2-methoxyphenyl)quinazolin-4(3H)-one
- 106611-74-9/2-(3,7,11,15,19,23-hexamethyl-25-(2,6,6-trimethylcyclohex-2-enyl)pentacosa-2,14,18,22-tetraenyl)-3-methyl-1,4-naphthoquinone
- 77448-87-4/Imidazo[2,1-b]quinazolin-2(3H)-one,7-bromo- 1,5-dihydro-3,6-dimethyl-
- 117211-88-8/1-[6-methoxy-6-methyl-8-(3,4,5-trimethoxyphenyl)-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-7-yl]ethanone
- 62390-99-2/2,2-dimethyl-5-[(5-nitrothiophen-2-yl)methylidene]-1,3-dioxane-4,6-dione
- 123131-49-7/4H-Dibenzo[de,g]quinolin-11(8H)-one,5,6,9,10-tetrahydro-10-hydroxy-1,2-dimethoxy-6-methyl-
- 26410-85-5/7-methyl-3-methyleneoct-6-ene
- 82199-06-2/N-[6-(2-Hydroxyethylsulfonyl)-2-naphtyl]acetamide
- 34565-32-7/(±)-Pestalotin
- 68424-33-9/Fatty acids, C5-9, mixed esters with pentaerythritol and valeric acid
- 33832-15-4/5aH,10aH-4a,9a-Epoxydibenzo[b,e][1,4]dioxin- 5a,10a-diol,octahydro-,(4aR,5aS,9aR,10aS)- rel-